Evidence map›Paper›PMID 33402736›Full record

ArticleBritish journal of cancer2021

The effectiveness of the Guy's Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients.

Saoirse Olivia Dolly, Geraint Jones, Paula Allchorne, Daniel Wheeler, Sunnyath Ali, Yaseen Mukadam, Sifan Zheng, Loay Rahman, Jan Sindhar, Charlotte Louise Moss and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05876676 (Rapid Diagnostic Centre Biomarker Study), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05876676 recruitingnot on this mapstarted 2023, after this paper: background citation

Rapid Diagnostic Centre Biomarker Study

Typeobservational_patient_registrySponsorRoyal Marsden NHS Foundation TrustRan2023 to 2032Enrolled1,000ConditionsCancer
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Saoirse Olivia DollyGuy's and St Thomas' NHS Foundation Trust (GSTT), Medical Oncology, London, UK. saoirse.dolly@gstt.nhs.uk.ORCID http://orcid.org/0000-0002-3401-318X
Geraint JonesGuy's and St Thomas' NHS Foundation Trust (GSTT), Medical Oncology, London, UK.
Paula AllchorneGuy's and St Thomas' NHS Foundation Trust (GSTT), Medical Oncology, London, UK.
Daniel WheelerKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Sunnyath AliKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Yaseen MukadamKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Sifan ZhengKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Loay RahmanKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Jan SindharKing's College London, Faculty of Life Sciences and Medicine, London, UK.
Charlotte Louise MossKing's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), London, UK.
Danielle HarariGuy's and St Thomas' NHS Foundation Trust (GSTT), Medical Oncology, London, UK.
Mieke Van HemelrijckKing's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), London, UK.
Anthony CunliffeJoint National Lead Macmillan GP Adviser and Joint Clinical Chair, South East London Cancer alliance, London, UK.
Luigi Vincenzo De MicheleGuy's and St Thomas' NHS Foundation Trust (GSTT), Medical Oncology, London, UK.
King's College London · GBGuy's and St Thomas' NHS Foundation Trust · GBLondon Cancer · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid Diagnostic Clinics (RDC) are being expanded nationally by NHS England. Guy's RDC established a pathway for GPs and internal referrals for patients with symptoms concerning for malignancy not suitable for a site-specific 2WW referral. However, little data assessing the effectiveness of RDC models are available in an English population.

methodsWe evaluated all patients referred to Guy's RDC between December 2016 and June 2019 (n = 1341) to assess the rate of cancer diagnoses, frequency of benign conditions and effectiveness of the service.

resultsThere were 96 new cancer diagnoses (7.2%): lung (16%), haematological (13%) and colorectal (12%)-with stage IV being most frequent (40%). Median time to definitive cancer diagnosis was 28 days (IQR 15-47) and treatment 56 days (IQR 32-84). In all, 75% were suitable for treatment: surgery (26%), systemic (24%) and radiotherapy (14%). Over 180 serious non-neoplastic conditions were diagnosed (35.8%) of patients with no significant findings in two-third of patients (57.0%).

conclusionsRDCs provide GPs with a streamlined pathway for patients with complex non-site-specific symptoms that can be challenging for primary care. The 7% rate of cancer diagnosis exceeds many 2WW pathways and a third of patients presented with significant non-cancer diagnoses, which justifies the need for rapid diagnostics. Rapid Diagnostic Centres (RDCs) are being rolled out nationally by NHS England and NHS Improvement as part of the NHS long-term plan. The aim is for a primary care referral pathway that streamlines diagnostics, patient journey, clinical outcomes and patient experience. This pilot study of 1341 patients provides an in-depth analysis of the largest single RDC in England. Cancer was diagnosed in 7% of patients and serious non-cancer conditions in 36%-justifying the RDC approach in vague symptom patients.

Indexed as

AgedEarly Detection of CancerFemaleFollow-Up StudiesHumansMedical AuditMiddle AgedNeoplasmsPilot ProjectsPrimary Health CarePrognosisProspective StudiesReferral and ConsultationRetrospective StudiesSymptom AssessmentTime Factors

Identifiers

PMID33402736
PMCPMC7783491
OpenAlexW3120628534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.